JDD Buzz Series | Social Media’s Impact on Hair Loss Information
hair lossSocial media is a major source of medical information, including information about hair loss. How reliable is the hair loss material presented on social media, and how does this information impact patients? Those are some of the questions posed by researchers in a study published in the March Journal of Drugs in Dermatology. I interviewed author Raymond Ezzat, third-year medical student at Geor …
hair loss
JDD Buzz Series | Sunscreens: Mechanisms and Safety in Depth
sunscreen[vc_row][vc_column][vc_column_text css=""]Despite decades of educational efforts, there is growing public skepticism over sunscreen’s safety and efficacy. Researchers from Chicago sought to synthesize the current scientific understanding of sunscreen in order to help dermatology clinicians address concerns. The findings are published in the February Journal of Drugs in Dermatology. I intervie …
sunscreen
JDD Buzz Series | Diversity in Melasma Clinical Trials
melasmaUnderrepresentation of patients with skin of color in clinical trials is an issue in medical research, including in research about dermatological conditions. A study in the January Journal of Drugs in Dermatology looked at the diversity of patients enrolled in melasma clinical trials to determine if there are any disparities in representation. I interviewed author Jared Jagdeo, MD, MS, associat …
melasma
JDD Buzz Series | Metformin’s Potential Chemopreventive Effect
metforminA commonly used diabetes medication may help prevent non-melanoma skin cancer. A study in the December Journal of Drugs in Dermatology analyzed whether metformin exposure is associated with a reduced risk of non-melanoma skin cancer. The study also stratified findings by race/ethnicity, which makes it unique among similar research studies. I interviewed author Tiffany Jow Libby, MD, FAAD, FACMS …
metformin
JDD Buzz Series | AI Chatbots in Dermatology
AI Chatbots in dermatologyAre AI chatbots a wave of the future in dermatology? An article in the November Journal of Drugs in Dermatology assessed dermatologists’ attitudes and beliefs toward artificial intelligence chatbots. Chatbot usage has grown in a variety of areas of society in recent years, and ChatGPT’s popularity shows there’s demand. So to what extent do dermatologists think AI chatbots will play a role in …
AI Chatbots in dermatology